Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Novavax COVID-19 Vaccine Coverage Update

Last updated on

Beginning July 13, 2022, the Texas Health and Human Services Commission (HHSC) covers the Novavax COVID-19 vaccine as a payable pharmacy benefit for Medicaid and Children’s Health Insurance Program (CHIP) clients who are 18 years of age or older. The Novavax COVID-19 vaccine is given as a two-dose primary series three weeks apart.

The U.S. Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for the Novavax COVID-19 vaccine.

Email with questions or comments.